PMID- 29569871 OWN - NLM STAT- MEDLINE DCOM- 20190208 LR - 20190215 IS - 2038-8306 (Electronic) IS - 1121-760X (Print) IS - 1121-760X (Linking) VI - 62 IP - 1 DP - 2018 Jan 22 TI - LOX-1 deficient mice show resistance to zymosan-induced arthritis. PG - 2847 LID - 10.4081/ejh.2018.2847 [doi] LID - 2847 AB - Recent data suggest that the lectin-like oxidized low-density lipoprotein (ox-LDL) receptor-1 (LOX-1)/ox-LDL system may be involved in the pathogenesis of arthritis. We aimed to demonstrate the roles of the LOX-1/ox-LDL system in arthritis development by using LOX-1 knockout (KO) mice. Arthritis was induced in the right knees of C57Bl/6 wild-type (WT) and LOX-1 KO mice via zymosan injection. Saline was injected in the left knees. Arthritis development was evaluated using inflammatory cell infiltration, synovial hyperplasia, and cartilage degeneration scores at 1, 3, and 7 days after administration. LOX-1, ox-LDL, and matrix metalloproteinase-3 (MMP-3) expression in the synovial cells and chondrocytes was evaluated by immunohistochemistry. The LOX-1, ox-LDL, and MMP-3 expression levels in synovial cells were scored on a grading scale. The positive cell rate of LOX-1, ox-LDL, and MMP-3 in chondrocytes was measured. The correlation between the positive cell rate of LOX-1 or ox-LDL and the cartilage degeneration score was also examined. Inflammatory cell infiltration, synovial hyperplasia, and cartilage degeneration were significantly reduced in the LOX-1 KOmice with zymosan-induced arthritis (ZIA) compared to WT mice with ZIA. In the saline-injected knees, no apparent arthritic changes were observed. LOX-1 and ox-LDL expression in synovial cells and chondrocytes were detected in the knees of WT mice with ZIA. No LOX-1 and ox-LDL expression was detected in the knees of LOX-1 KOmice with ZIA or the saline-injected knees of both mice. MMP-3 expression in the synovial cells and chondrocytes was also detected in knees of both mice with ZIA, and was significantly less in the LOX-1 KO mice than in WT mice. The positive cell rate of LOX-1 or ox-LDL and the cartilage degeneration score showed a positive correlation. Our data show the involvement of the LOX-1/ox-LDL system in murine ZIA development. LOX-1-positive synovial cells and chondrocytes are potential therapeutic targets for arthritis prevention. FAU - Hashimoto, Kazuhiko AU - Hashimoto K AD - Kindai University Hospital. hazzhiko@med.kindai.ac.jp. FAU - Oda, Yutaka AU - Oda Y FAU - Nakagawa, Koichi AU - Nakagawa K FAU - Ikeda, Terumasa AU - Ikeda T FAU - Ohtani, Kazuhiro AU - Ohtani K FAU - Akagi, Masao AU - Akagi M LA - eng PT - Journal Article DEP - 20180122 PL - Italy TA - Eur J Histochem JT - European journal of histochemistry : EJH JID - 9207930 RN - 0 (OLR1 protein, human) RN - 0 (Scavenger Receptors, Class E) RN - 9010-72-4 (Zymosan) SB - IM MH - Animals MH - Arthritis/*chemically induced/physiopathology MH - Disease Models, Animal MH - Disease Resistance/genetics MH - Gene Deletion MH - Gene Knockout Techniques MH - Immunohistochemistry MH - Knee Joint/pathology MH - Mice MH - *Scavenger Receptors, Class E/genetics MH - Synovial Fluid/cytology MH - Zymosan/*toxicity PMC - PMC5806501 OTO - NOTNLM OT - Arthritis OT - Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) OT - oxidized low-density lipoprotein (ox-LDL) COIS- Conflict of interest: The authors declare no conflict of interest. EDAT- 2018/03/24 06:00 MHDA- 2019/02/09 06:00 PMCR- 2018/01/22 CRDT- 2018/03/24 06:00 PHST- 2017/09/02 00:00 [received] PHST- 2018/01/08 00:00 [accepted] PHST- 2018/01/03 00:00 [revised] PHST- 2018/03/24 06:00 [entrez] PHST- 2018/03/24 06:00 [pubmed] PHST- 2019/02/09 06:00 [medline] PHST- 2018/01/22 00:00 [pmc-release] AID - 10.4081/ejh.2018.2847 [doi] PST - epublish SO - Eur J Histochem. 2018 Jan 22;62(1):2847. doi: 10.4081/ejh.2018.2847.